Skip to main content
. 2018 Apr 4;9:199. doi: 10.3389/fphar.2018.00199

FIGURE 7.

FIGURE 7

The mode of action of xanthohumol. Xn treatment suppressed AD-related changes, notably Aβ and tau phosphorylation via APP processing and the GSK-3β and PP2A pathways, which may be attributed to modifications of proteins related to functions of oxidative stress, ER stress, proteasomes and molecular chaperones.